Product information

Current status:

Cancelled Post Market

Current status date:

1997-07-30

Original market date: ^{See footnote 1}

1985-12-31

Product name:

OMNIPAQUE 300 LIQ IV SAR 647MG/ML

DIN:

02018128 Electronic product monograph is not available

Company:

SANOFI CANADA, INC.
15 Allstate Pky
Markham
Ontario
Canada L3R 5B4

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Subarachnoidal ,  Intravenous

Number of active ingredient(s):

1

Schedule(s):

Ethical

American Hospital Formulary Service (AHFS): ^{See footnote 3}

36:68.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

V08AB02 IOHEXOL

Active ingredient group (AIG) number:^{See footnote5}

0103970029